UY34415A - Composiciones hemostáticas - Google Patents

Composiciones hemostáticas

Info

Publication number
UY34415A
UY34415A UY0001034415A UY34415A UY34415A UY 34415 A UY34415 A UY 34415A UY 0001034415 A UY0001034415 A UY 0001034415A UY 34415 A UY34415 A UY 34415A UY 34415 A UY34415 A UY 34415A
Authority
UY
Uruguay
Prior art keywords
hemostatic compositions
hemostatic
compositions
figura
hay
Prior art date
Application number
UY0001034415A
Other languages
English (en)
Inventor
Paul J Sanders
Donovan Shane
Dande Prasad
Mark A Nordhaus
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of UY34415A publication Critical patent/UY34415A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/104—Gelatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0038—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Abstract

La invención divulga un método para producir una composición hemostática que comprende mezclar un polímero biocompatible adecuado para el uso en hemostasis y un reticulador tipo genipina, reticular dicho polímero por dicho reticulador tipo genipina para obtener un polímero biocompatible reticulado, y convertir dicho polímero reticulado en una composición hemostática farmacéuticamente aceptable, nuevas composiciones hemostáticas y métodos para usar tales composiciones.
UY0001034415A 2011-10-27 2012-10-25 Composiciones hemostáticas UY34415A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161552323P 2011-10-27 2011-10-27

Publications (1)

Publication Number Publication Date
UY34415A true UY34415A (es) 2013-05-31

Family

ID=47115904

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034415A UY34415A (es) 2011-10-27 2012-10-25 Composiciones hemostáticas

Country Status (4)

Country Link
US (1) US20130129710A1 (es)
TW (1) TW201332567A (es)
UY (1) UY34415A (es)
WO (1) WO2013060769A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9999702B2 (en) 2010-04-09 2018-06-19 Kci Licensing Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
CN103435821B (zh) * 2013-08-29 2015-09-09 天津大学 京尼平交联弹性蛋白水凝胶及其制备方法
CN104710635B (zh) * 2013-08-29 2017-03-01 天津大学 京尼平交联弹性蛋白水凝胶的制备方法
CA2968104A1 (en) 2014-12-19 2016-06-23 Baxter International Inc. Flowable hemostatic composition
GB201508024D0 (en) 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions
US10660945B2 (en) 2015-08-07 2020-05-26 Victor Matthew Phillips Flowable hemostatic gel composition and its methods of use
US10751444B2 (en) 2015-08-07 2020-08-25 Victor Matthew Phillips Flowable hemostatic gel composition and its methods of use
CN106822986B (zh) * 2017-04-07 2019-11-12 广东海洋大学 一种壳聚糖-琼胶低聚糖多孔球珠止血材料的制备方法
CN106975098B (zh) * 2017-04-13 2020-07-07 赛克赛斯生物科技股份有限公司 一种复合多糖止血组合物及其制备方法与应用
KR101989054B1 (ko) * 2017-11-28 2019-06-13 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
US20210236642A1 (en) * 2018-07-26 2021-08-05 Srinivas Reddy Male Haemostatic gel composition and its process of preparation
CN110339391A (zh) * 2019-08-09 2019-10-18 北京诺康达医药科技股份有限公司 新型可降解的止血材料及其制备方法
TWI788088B (zh) * 2020-11-18 2022-12-21 國立成功大學 用於製備止血組合物之止血材料及其用途
CN114507364B (zh) * 2022-02-15 2022-07-26 浙江大学 光固化酪蛋白水凝胶的制法及在止血和皮肤修复上的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270446A (en) * 1989-04-04 1993-12-14 Suntory Limited Decolorized crosslinked products and method for decolorization of crosslinked products
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
WO1998019718A1 (en) 1996-11-05 1998-05-14 Challenge Bioproducts Co., Ltd. Chemical modification of biomedical materials with genipin
US20100254900A1 (en) * 2002-03-18 2010-10-07 Campbell Phil G Biocompatible polymers and Methods of use
US8119160B2 (en) * 2004-06-29 2012-02-21 Ethicon, Inc. Hemostatic compositions and devices
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
WO2008076407A2 (en) * 2006-12-15 2008-06-26 Lifebond Ltd. Gelatin-transglutaminase hemostatic dressings and sealants
US20100111919A1 (en) * 2008-10-31 2010-05-06 Tyco Healthcare Group Lp Delayed gelation compositions and methods of use

Also Published As

Publication number Publication date
TW201332567A (zh) 2013-08-16
US20130129710A1 (en) 2013-05-23
WO2013060769A2 (en) 2013-05-02
WO2013060769A3 (en) 2013-06-20

Similar Documents

Publication Publication Date Title
UY34414A (es) Composiciones hemostáticas
UY34415A (es) Composiciones hemostáticas
CO7111289A2 (es) Compuestos inhibidores de metaloenzimas
DK3513803T3 (da) Hæmostatiske sammensætninger
SMT201700050B (it) Composizioni anestetiche termogelificanti
UY34550A (es) Bencilpirazoles sustituidos
FR2997014B1 (fr) Composition sterile dermo-injectable
DK2640893T4 (da) Sammensætninger
BR112013022112A2 (pt) composição
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
BR112013022102A2 (pt) composição
BR112014003052A2 (pt) composições farmacêuticas
UY33930A (es) Inhibidores novedosos de quinasas
CO7091177A2 (es) Inhibidores de la beta-secretasa
CO6930368A2 (es) Composiciones de yodo-povidona estable
BR112015012907A2 (pt) composição de cuidado pessoal
CO6930367A2 (es) Composiciones farmaceúticas
BR112014009802A2 (pt) composições de bismaleimida contendo nanossílica
BR112014002403A2 (pt) composição dentifrícia não aquosa
BR112014003027A2 (pt) formulação herbicida melhorada
UY34158A (es) Composicion herbicida
BR112013033808A2 (pt) composição
BR112014009761A2 (pt) composição oftálmica
UY34483A (es) Polipeptido
UY34702A (es) Composiciones y métodos agrícolas u hortícolas

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20201020